Inventiva S.A. IVA

Updated: 18 Jun 2026

NASDAQ | Biotech | Biotech / MASH therapies

No signal published yet

We already track Inventiva S.A. and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Inventiva S.A. free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotech / MASH therapies
We're already tracking Inventiva S.A. — here are the latest events we've registered

Recent News

  • On June 2, 2026, Inventiva announced a comprehensive capital structure optimization involving a $120 million equity offering and up to €150 million in new debt financing. The funding is intended to support operations through the anticipated Phase 3 topline results for lanifibranor in the fourth quarter of 2026. The company also agreed to repurchase warrants from the European Investment Bank to mitigate future shareholder dilution.

What Firelda Watch includes for Inventiva S.A.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Inventiva S.A. will be delivered in the same format.

Want to follow Inventiva S.A.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Inventiva S.A. free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Inventiva S.A. IVA
Inventiva S.A. — follow and we'll monitor it
Follow Inventiva S.A. free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.